openPR Logo
Press release

Peripheral IV Catheter Market is Expected to Progress at a CAGR of 5.8% to Reach US$ 1,865.4 Million by 2034 | Fact.MR Report

05-02-2024 10:00 AM CET | Health & Medicine

Press release from: Fact.MR

Peripheral IV Catheter Market

Peripheral IV Catheter Market

The peripheral IV catheter market in US is predicted to account for 88.6% of the North American market in 2024. It is projected that the US market for peripheral IV catheters would grow by US$ 685 million by 2024. By 2034, the market is expected to reach US$ 1,029 million with a 4.2% compound annual growth rate.

It is projected that the size of the peripheral IV catheter market worldwide would reach US$ 1,058.6 million by 2024. By 2034, the market is expected to grow at a 5.8% CAGR and reach US$ 1,865.4 million.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.factmr.com/connectus/sample?flag=S&rep_id=9654

For public relations (PR) specialists, the peripheral I.V. catheter market offers a distinctive environment with a wealth of chances for strategic communication and brand development. We will examine the dynamics, difficulties, and future growth potential of the Peripheral IV Catheter market in this study, highlighting the critical role public relations plays in influencing attitudes, building connections, and propelling commercial success. The global peripheral I.V. catheter market is expected to rise steadily over the next several years due to a mix of ongoing technology advancements, greater environmental consciousness, and an increasing demand for more efficient operations. It is expected that industry participants would focus on product innovation, strategic partnerships, and global expansion in order to take advantage of the changing market prospects.

๐“๐จ๐ฉ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐๐ซ๐จ๐ฉ๐ž๐ฅ๐ฅ๐ข๐ง๐  ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐๐ž๐ซ๐ข๐ฉ๐ก๐ž๐ซ๐š๐ฅ ๐ˆ๐• ๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Peripheral IV catheter sales are benefiting from an aging population and an increase in the prevalence of chronic illnesses.
The market is being driven by a rise in the number of hospitalizations and a notable use of safety-ported short peripheral intravenous catheters.
Peripheral IV catheter use is predicted to be significantly accelerated by the desire to reduce needle-stick injuries and growing healthcare costs.
Peripheral IV catheter use is rising as more people become aware of the benefits of early diagnosis in obtaining blood samples for testing.
Peripheral intravenous catheter use is rising as a result of the rise in chronic illnesses like diabetes, neurological diseases, infectious disorders, etc. that are creating opportunities for players to conduct disease treatment awareness campaigns.
The market is expected to grow as a result of investments made in the development and production of effective peripheral IV catheters, given the growing patient population.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

Key players in the peripheral IV catheter market include Becton, Dickinson, and Company, B. Braun Melsungen AG, Smiths Group plc., Terumo Corporation, Venner Medical, Vygon, Teleflex Incorporated, C. R. Bard, Inc., NIPRO Medical Corporation, and Argon Medical Devices, Inc.

There are both domestic and foreign competitors in this fiercely competitive market. Small and medium-sized businesses are focusing on increasing their market share by investing in technology innovations. Players also use other inorganic and organic tactics, like as alliances, mergers, acquisitions, and the introduction of new products.

Recent Developments in the Peripheral IV Catheter Market

In September 2022, B. Braun Medical Inc. purchased numerous items from Starboard Medical. These devices are used to fasten the Clik-FIX peripheral catheter.

In March 2022, Shockwave Medical Inc. announced that the Shockwave M5+ peripheral IVL catheter-which received FDA certification and the CE Mark-will be made commercially accessible globally.

In July 2022, B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter, which allows for single-time blood control. The most recent invention from B. Braun lowers the risk of needlestick injuries and blood exposure while also improving the safety quotient of IV for medical professionals.

๐†๐ž๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9654

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ž๐ซ๐ข๐ฉ๐ก๐ž๐ซ๐š๐ฅ ๐ˆ๐• ๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

By Product Type:
Power Injected PICC
Conventional PICC

By Design Type:
Single Lumen
Double Lumen
Multiple Lumen

By End User:
Hospitals
Ambulatory Surgical Centers
Catheterization Labs

By Region:
North America
Europe
Latin America
East Asia
South Asia and Oceania
Middle East and Africa

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral IV Catheter Market is Expected to Progress at a CAGR of 5.8% to Reach US$ 1,865.4 Million by 2034 | Fact.MR Report here

News-ID: 3482260 • Views: โ€ฆ

More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C., Hydro Flask Lead - Fact.MR
Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C โ€ฆ
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics. The marketโ€ฆ
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L โ€ฆ
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-worldโ€ฆ
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 โ€ฆ
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays aโ€ฆ
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 โ€ฆ
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stableโ€ฆ

All 5 Releases


More Releases for Peripheral

Peripheral Vascular Devices Market - Advancing vascular health: Cutting-edge dev โ€ฆ
Newark, New Castle, USA: The "Peripheral Vascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Peripheral Vascular Devices Market: https://www.growthplusreports.com/report/peripheral-vascular-devices-market/7820 This latest report researches the industry structure,โ€ฆ
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re โ€ฆ
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitiveโ€ฆ
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele โ€ฆ
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview ofโ€ฆ
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera โ€ฆ
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentationโ€ฆ
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, โ€ฆ
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorderโ€ฆ
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip โ€ฆ
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering aโ€ฆ